Please ensure Javascript is enabled for purposes of website accessibility

Video: Outperformance of Small-Cap Stocks | Cabot Weekly Review

In this week’s video, Tyler Laundon recaps the market moving economic and earnings releases from the last week then lays out what investors should expect from the Fed next week, and into December.

In this week’s video, Tyler Laundon recaps the market moving economic and earnings releases from the last week then lays out what investors should expect from the Fed next week, and into December. Tyler thinks next week is the moment the Fed decides if it wants a hard or soft landing as far as the stock market is concerned. Tyler highlights the recent outperformance of small cap stocks and suggests reasons behind the move. He then digs into small cap MedTech names set to report over the next two weeks. Stocks mentioned: AXNX RGEN PRCT TMDX SIGN FNA.

Get It While It’s Hot!

Be among the first to see the Cabot Weekly Review when it comes out. Have it delivered right to your inbox every Saturday. Get on the list:

[form src='/form/cabot-weekly-review’]
Along with your weekend video, you will receive our free weekday advisory, Cabot Wealth Daily, with top stock picks, market news and insightful commentary from our analysts.

[author_ad]

Tyler Laundon is chief analyst of the limited-subscription advisory, Cabot Small-Cap Confidential and grand slam advisory Cabot Early Opportunities. He has spent his entire career managing, consulting and analyzing start-up and small-cap companies. His hands-on experience has taught Tyler that the development of a superior business model is the biggest factor in determining a company’s long-term success. Accordingly, his research focuses on assessing the viability of management’s growth strategies, trends in addressable markets and achievement of major developmental milestones.